Pharmaceutical companies protecting their profits through patent protection laws, which prevent other countries from producing generic versions of the COVID vaccine, are the greatest obstacles to a more efficient global distribution of vaccines.
Pharmaceutical companies protecting their profits through patent protection laws, which prevent other countries from producing generic versions of the COVID vaccine, are the greatest obstacles to a more efficient global distribution of vaccines.